The “overweight” rating that Piper Sandler’s stock analysts gave Livent was reiterated in a note sent out to investors on Tuesday (NYSE: LTHM). They currently have a target price of $42.00 for the stock, which they want to achieve. When compared to the stock’s most recent closing price, Piper Sandler’s price objective indicates a potential value gain equal to or greater than 21.18 percent. Due to recent occurrences, an expanded number of research analysts are focusing on LTHM. In a research note released on Tuesday, August 9, Citigroup stated that they had increased their price objective on Livent to $27.00. Shares of Livent were given a ” hold ” rating in a research note published on July 6, and Deutsche Bank Aktiengesellschaft lowered its price objective for the stock from $29.00 to $24.00 as a result of the downgrade.
The company Livent was given a grade of “b-” rather than a rating of “c+” in a research report published by TheStreet on Tuesday, August 9. The report was on the company’s performance during the previous three months. In a statement that was made available to the general public on Monday, September 12, Vertical Research lowered their recommendation for Livent from “buy” to “hold” and increased their price objective for the company from $33 to $35 in a report that was lowered to “sell. Both of these alterations were carried out. The CICC Study started including Livent as a topic of discussion in one of their research papers on Monday, August 8. They gave the company an “outperform” rating and a price objective in the range of $27.30 to $27.30 for its stock. Seven research experts have recommended buying the stock, five research experts have recommended keeping it, and one research expert has classified it as a sell.
According to Bloomberg, the vast majority of market experts now have the stock rated as “Hold,” and the average price goal they have set for the stock is $30.85. On Tuesday, trading on the NYSE LTHM got underway at $34.66 per share. Some of the current financial ratios include a debt-to-equity ratio of 0.19, a current ratio of 2.60, and a quick ratio of 1.55. The previous year’s cost of Livent ranged from a low of $19.35 to a high of $36.38. The company’s stock has a price-to-earnings ratio currently sitting at 63.02, and its beta value currently sits at 1.88. The value of the company’s stock on the market is now estimated to be $6.21 billion. The price of a share of the company’s stock is presently trading at $28.18 (the fifty-day moving average), while the price of a share of the stock is currently trading at $26.18 (the 200-day moving average).
The most recent quarterly report for Livent (NYSE: LTHM) was made available to the general public on August 2. The company reached quarterly earnings of $0.37 per share, which was $0.07 more than the consensus forecast among analysts, which was $0.30 per share. The return on equity for Livent came in at 14.62 percent, and the net margin for the company was 18.36 percent. The company reported a profit of $0.04 per share for the same period the year before when compared to the current year. 2017 is expected to bring in $1.38 for each share of Livent stock, according to forecasts made by financial analysts.
On September 9, Paul W. Graves, the Chief Executive Officer of Livent, sold 85,171 shares of the company’s stock. This is only one of the many recent happenings. The number of sold shares contributed to a total sales volume of $2,980,985.00, and the stock was sold at an average price of $35.00 per share. After the completion of the sale, the chief executive officer holds a total of 299,980 business shares, equivalent to approximately $10,499,300 in value. Legal paperwork regarding the transaction has been submitted to the Securities and Exchange Commission, and it can be accessed on this website whenever it is most convenient for you. Company insiders own 1.18 percent of the total number of shares currently outstanding in the corporation.
In recent times, a select few hedge funds have made some modifications to the strategy through which they invest in LTHM. The value of BlackRock Inc.’s investment in Livent increased by 3.2% over the first three months of 2018. BlackRock Inc. now has a total of 25,674,467 shares of the company’s stock, which are currently valued at $669,334,000 following the purchase of an additional 797,187 shares during the most recent quarter. During the first three months of 2018, Vanguard Group Inc. boosted the number of Livent shares that comprised its portfolio by 0.6%. After purchasing an additional 109,353 shares of the company’s stock during the most recent fiscal quarter, Vanguard Group Inc. now directly owns 17,627,545 shares of the corporation, which has a value of $459,549,000. This brings the total number of shares that Vanguard Group Inc. During the first three months of 2018, Wellington Management Group LLP successfully raised the percentage of Livent shares it owned by 5.7%.
After making an additional purchase of 421,082 shares during the most recent quarter, Wellington Management Group LLP now has 7,824,996 shares of the company’s stock. This gives the firm a combined value of $203,997,000, greater than the value of the shares it had before the most recent purchase. During the second quarter, State Street Corporation accomplished an increase of 1.9% in the proportion of Livent stock that it owned. State Street Corp now owns 5,289,249 shares of the company after purchasing an additional 99,374 shares during the quarter. The current value of this holding is $120,013,000. Last but not least, Allianz Asset Management GmbH increased the percentage of Livent shares that it owned by 35.7% during the first quarter. This certainly should not be considered the least important development. Allianz Asset Management GmbH now possesses a total of 2,799,333 shares of the firm’s stock, which are now valued at $72,979,000 following the acquisition of an additional 736,174 shares over the period in question. This brings the total number of shares owned by the company to 2,799,333. Institutional investors and hedge funds own 87.57% of the company’s stock.
The Livent Corporation is a global company that produces and sells high-performance lithium compounds worldwide, including in regions such as North America, Latin America, Europe, the Middle East, Africa, and Asia-Pacific. The production of lithium-ion batteries, specialized polymers, and chemical synthesis all make use of these lithium compounds. The company offers a wide variety of specialty lithium compounds, some of which include high purity lithium metal, which is used in non-rechargeable batteries and the creation of lightweight materials for aeronautics, as well as lithium compounds for use in high-performance applications, such as battery-grade lithium hydroxide for use in high-performance lithium-ion batteries; butyllithium, which is used in the production of polymers and pharmaceutical products; and other sulfonated lithium compounds. The company also provides lithium compounds. Additionally, the company provides a selection of different specialized lithi “